Table 1: Demographic and Clinical Characteristics - Rheumatoid_arthritis_&_osteoarthritis
	Total	non-current NSAID use	current NSAID use

1	  1708781 (100.0)	  1533286 (100.0)	  175,495 (100.0)

Grouped age
1	   37,391 (2.2)	   32,958 (2.1)	    4,433 (2.5)
2	  113,683 (6.7)	   97,870 (6.4)	   15,813 (9.0)
3	  337,583 (19.8)	  292,186 (19.1)	   45,397 (25.9)
4	  473,436 (27.7)	  416,489 (27.2)	   56,947 (32.4)
5	  477,827 (28.0)	  436,477 (28.5)	   41,350 (23.6)
6	  268,861 (15.7)	  257,306 (16.8)	   11,555 (6.6)

Male
0	  1061943 (62.1)	  951,417 (62.1)	  110,526 (63.0)
1	  646,838 (37.9)	  581,869 (37.9)	   64,969 (37.0)

Grouped BMI
1	   20,876 (1.2)	   19,616 (1.3)	    1,260 (0.7)
2	  410,764 (24.0)	  379,233 (24.7)	   31,531 (18.0)
3	  573,989 (33.6)	  518,602 (33.8)	   55,387 (31.6)
4	  339,018 (19.8)	  298,505 (19.5)	   40,513 (23.1)
5	  139,348 (8.2)	  119,286 (7.8)	   20,062 (11.4)
6	   71,197 (4.2)	   58,801 (3.8)	   12,396 (7.1)
.	  153,589 (9.0)	  139,243 (9.1)	   14,346 (8.2)

Smoking status
1	  743,116 (43.5)	  672,833 (43.9)	   70,283 (40.0)
2	  773,147 (45.2)	  692,164 (45.1)	   80,983 (46.1)
3	  188,377 (11.0)	  164,464 (10.7)	   23,913 (13.6)
.	    4,141 (0.2)	    3,825 (0.2)	      316 (0.2)

Smoking status (missing set to non)
1	  747,257 (43.7)	  676,658 (44.1)	   70,599 (40.2)
2	  773,147 (45.2)	  692,164 (45.1)	   80,983 (46.1)
3	  188,377 (11.0)	  164,464 (10.7)	   23,913 (13.6)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)

Ethnicity
1	  1221055 (71.5)	  1095982 (71.5)	  125,073 (71.3)
2	    7,393 (0.4)	    6,563 (0.4)	      830 (0.5)
3	   58,556 (3.4)	   51,587 (3.4)	    6,969 (4.0)
4	   19,751 (1.2)	   17,645 (1.2)	    2,106 (1.2)
5	   12,157 (0.7)	   10,916 (0.7)	    1,241 (0.7)
.	  389,869 (22.8)	  350,593 (22.9)	   39,276 (22.4)

Index of Multiple Deprivation (IMD)
1	  344,498 (20.2)	  313,701 (20.5)	   30,797 (17.5)
2	  342,318 (20.0)	  309,372 (20.2)	   32,946 (18.8)
3	  342,266 (20.0)	  307,669 (20.1)	   34,597 (19.7)
4	  340,541 (19.9)	  303,859 (19.8)	   36,682 (20.9)
5	  339,158 (19.8)	  298,685 (19.5)	   40,473 (23.1)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)

Diabetes Severity
1	  1442997 (84.4)	  1293742 (84.4)	  149,255 (85.0)
2	  196,932 (11.5)	  177,397 (11.6)	   19,535 (11.1)
3	   64,738 (3.8)	   58,452 (3.8)	    6,286 (3.6)
4	    4,114 (0.2)	    3,695 (0.2)	      419 (0.2)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)

Diabetes Severity: group no Hb1AC with uncontrolled DM
1	  1442997 (84.4)	  1293742 (84.4)	  149,255 (85.0)
2	  196,932 (11.5)	  177,397 (11.6)	   19,535 (11.1)
3	   68,852 (4.0)	   62,147 (4.1)	    6,705 (3.8)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)

Rheumatoid arthritis/osteoarthritis/both
.	        0 (0.0)	        0 (0.0)	        0 (0.0)
1	   72,272 (4.2)	   59,453 (3.9)	   12,819 (7.3)
2	  1592199 (93.2)	  1438230 (93.8)	  153,969 (87.7)
3	   44,310 (2.6)	   35,603 (2.3)	    8,707 (5.0)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)

Diagnosed hypertension
0	  1017436 (59.5)	  908,039 (59.2)	  109,397 (62.3)
1	  691,345 (40.5)	  625,247 (40.8)	   66,098 (37.7)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)

Heart Failure
0	  1670480 (97.8)	  1496398 (97.6)	  174,082 (99.2)
1	   38,301 (2.2)	   36,888 (2.4)	    1,413 (0.8)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)

Other Heart Diseases
0	  1646603 (96.4)	  1475310 (96.2)	  171,293 (97.6)
1	   62,178 (3.6)	   57,976 (3.8)	    4,202 (2.4)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)

Diabetes
0	  1442997 (84.4)	  1293742 (84.4)	  149,255 (85.0)
1	  265,784 (15.6)	  239,544 (15.6)	   26,240 (15.0)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)

COPD
0	  1614550 (94.5)	  1447428 (94.4)	  167,122 (95.2)
1	   94,231 (5.5)	   85,858 (5.6)	    8,373 (4.8)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)

Other Respiratory Diseases
0	  1667098 (97.6)	  1495038 (97.5)	  172,060 (98.0)
1	   41,683 (2.4)	   38,248 (2.5)	    3,435 (2.0)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)

Cancer
0	  1518194 (88.8)	  1358639 (88.6)	  159,555 (90.9)
1	  190,587 (11.2)	  174,647 (11.4)	   15,940 (9.1)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)

Immunosuppressed (combination algorithm)
0	  1699274 (99.4)	  1524788 (99.4)	  174,486 (99.4)
1	    9,507 (0.6)	    8,498 (0.6)	    1,009 (0.6)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)

Chronic kidney disease
0	  1532648 (89.7)	  1368301 (89.2)	  164,347 (93.6)
1	  176,133 (10.3)	  164,985 (10.8)	   11,148 (6.4)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)

Osteoarthritis
0	   72,272 (4.2)	   59,453 (3.9)	   12,819 (7.3)
1	  1636509 (95.8)	  1473833 (96.1)	  162,676 (92.7)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)

Rheumatoid arthritis
0	  1592199 (93.2)	  1438230 (93.8)	  153,969 (87.7)
1	  116,582 (6.8)	   95,056 (6.2)	   21,526 (12.3)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)

Flu vaccine
0	  816,202 (47.8)	  727,222 (47.4)	   88,980 (50.7)
1	  892,579 (52.2)	  806,064 (52.6)	   86,515 (49.3)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)

Pneumococcal Vaccine
0	  1490892 (87.2)	  1340141 (87.4)	  150,751 (85.9)
1	  217,889 (12.8)	  193,145 (12.6)	   24,744 (14.1)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)

Recent Statin
0	  1246641 (73.0)	  1118166 (72.9)	  128,475 (73.2)
1	  462,140 (27.0)	  415,120 (27.1)	   47,020 (26.8)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)

Recent PPIs
0	  1200137 (70.2)	  1161822 (75.8)	   38,315 (21.8)
1	  508,644 (29.8)	  371,464 (24.2)	  137,180 (78.2)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)

Recent oral prednisolone
0	  1639260 (95.9)	  1472030 (96.0)	  167,230 (95.3)
1	   69,521 (4.1)	   61,256 (4.0)	    8,265 (4.7)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)

Recent hydroxychloroquine
0	  1686894 (98.7)	  1516503 (98.9)	  170,391 (97.1)
1	   21,887 (1.3)	   16,783 (1.1)	    5,104 (2.9)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)

Recent Other DMARDs use
0	  1647209 (96.4)	  1484467 (96.8)	  162,742 (92.7)
1	   61,572 (3.6)	   48,819 (3.2)	   12,753 (7.3)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)

GP consultation in last year (binary)
0	  132,876 (7.8)	  128,212 (8.4)	    4,664 (2.7)
1	  1575905 (92.2)	  1405074 (91.6)	  170,831 (97.3)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)

A&E attendance rate in last year (binary)
0	  1402196 (82.1)	  1261555 (82.3)	  140,641 (80.1)
1	  306,585 (17.9)	  271,731 (17.7)	   34,854 (19.9)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)



GP consultation count
Median (IQR)	6 (3-12)	6 (3-11)	8 (5-14)
Min, Max	0, 468	0, 468	0, 360
Age (years)
Median (IQR)	67 (58-75)	68 (58-76)	63 (55-71)
Min, Max	18, 110	18, 110	18, 103
A&E attendance count
Median (IQR)	0 (0-0)	0 (0-0)	0 (0-0)
Min, Max	0, 71	0, 71	0, 63
Number of days (follow-up) for ONS covid death
Median (IQR)	105 (105-105)	105 (105-105)	105 (105-105)
Min, Max	1, 105	1, 105	1, 105
